| K-number | K220480 |
| Device name | Revogene |
| Applicant | Meridian Bioscience, Inc. |
| Product code | OOI |
| Device class | Class II |
| Decision date | Jul 11, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 862.2570 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov